Charter Research

Orlando, Florida 32803

11 studies enrolling now · 19 studies all time

What they study most

Agitation Associated With Alzheimer's Dementia, Alzheimer Disease, Alzheimer Disease, Early Onset, Alzheimer's Disease, Alzheimer's Disease, Early Onset, Body Weight, Dementia, Early Alzheimer's Disease, Early Preclinical Alzheimer's Disease, Liver Fibrosis, Major Depressive Disorder, Memory Disorders

Studies at this site

• LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis — Recruiting now
• A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend) — Recruiting now
• LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis — Recruiting now
• Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus — Recruiting now
• A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia — Recruiting now
• A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1) — Recruiting now
• "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder" — Recruiting now
• A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease — Recruiting now
• Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia — Recruiting now
• A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge) — Running, not enrolling
• Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND) — Enrolling by invitation
• PMN310 in Patients With Early Alzheimer's Disease (PRECISE-AD) — Running, not enrolling
• A Study of BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH) With an Extension — Completed
• Alzheimer's Disease Neuroimaging Initiative 4 — Enrolling by invitation
• Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects — Stopped early
• An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects — Completed
• A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease — Running, not enrolling
• Alzheimer's Plasma Extension — Running, not enrolling
• Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease — Completed